Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of Neuroinflammation

Author:

Tangherlini Giovanni1,Kalinin Dmitrii V.1,Schepmann Dirk1,Che Tao2,Mykicki Nadine34,Ständer Sonja3,Loser Karin345,Wünsch Bernhard15ORCID

Affiliation:

1. Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstraße 48, D-48149 Münster, Germany

2. Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

3. Department of Dermatology, University of Münster, von-Esmarch-Street 58, D-48149 Münster, Germany

4. CRC1009 Breaking Barriers and CRC-TR 128 Multiple Sclerosis, University of Münster, D-48149 Münster, Germany

5. Cells-in-Motion Cluster of Excellence (EXC 1003—CiM), Westfälische Wilhelms-Universität Münster, D-48149 Münster, Germany

Funder

Deutsche Forschungsgemeinschaft

National Institute on Drug Abuse

National Institute of Mental Health

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3